SSWM
HZNP

Sheets Smith Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sheets Smith Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,563
Closed -$384K – 396
2021
Q4 		$384K Buy
3,563
+4
+0.1% +$436 0.05% 268
2021
Q3 		$390K Buy
3,559
+20
+0.6% +$2.08K 0.05% 253
2021
Q2 		$331K Buy
+3,539
New +$326K 0.04% 285
2019
Q3 		– Sell
-21,766
Closed -$524K – 329
2019
Q2 		$524K Sell
21,766
-203
-0.9% -$5.15K 0.11% 199
2019
Q1 		$581K Buy
21,969
+5,875
+37% +$139K 0.13% 177
2018
Q4 		$314K Buy
+16,094
New +$315K 0.08% 221
2015
Q3 		– Sell
-27,715
Closed -$963K – 243
2015
Q2 		$963K Buy
+27,715
New +$846K 0.26% 112

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return